Published Aug 2, 2016

Dr Kaufman speaks with ecancertv at ASCO 2016 to discuss the results of phase II JAVELIN Merkel 200 trial, in which patients with metastatic Merkl cell carcinoma received avelumab, a PD-L1 checkpoint inhibitor.

Merkel cell carcinoma (MCC) is an aggressive skin cancer associated with Merkel cell polyomavirus, with limited therapeutic options after 1st-line chemotherapy.

Dr Kaufman describes the results of the JAVELIN trial in which, of a cohort of 88, six patients (9.8%) achieved complete responses, 12 (19.7%) had partial responses, and 7 (11.5%) had stable disease (83.3% responses were ongoing).

He also details the ongoing progression free survival data, and offers that additional clinical evaluation of avelumab for is warranted.


Published on Jul 31, 2015

Learn more about radiation therapy treatment from a patient's perspective. Find out how long appointments last, what to expect during the treatment, and also what the side effects may be from treatment.


Learn about how radiation is used to treat cancer. Both external beam and internal (brachytherapy/bead) radiation treatments are described.

To learn more about cancer and watch additional interviews, please visit the CancerQuest website at

5:25 Why do some people get cancer, and other people don't? Can this cancer-fighting capability be transferred from one person to another? This fundraising video for a cancer treatment research group seeks funding for a human clinical trial for a game-changing new treatment.


A quick description of what we will be speaking about in our first class of our Wellness Series with Essential Oils. April 1st class will be on Preventing and Coping with Cancer.


You can buy all doTERRA products through this link: Thanks for watching!


This is my personal experience on my ongoing struggle with the type of cancer known as Non-Hodgkin Lymphoma. Therapeutic grade Sacred Frankincense Essential Oil from helped me clear the swelling in a cancerous lymph node on my neck. You can write to me at